30 Currently, biomarkers play a fundamental role in the diagnosis, prognosis, classification, and personalized treatment of AL, making them highly significant in clinical practice. 38 Conventional methods—such as flow cytometry, cytogenetic analyses, and molecular techniques—remain the gold standard for diagnosing AL due to their good sensitivity and specificity. 17 These methods are widely used and are well-established in clinical settings.
← all excerpts
Clinical Peptidomics in Acute Leukemias: Current Advances and Future Perspectives.
1
—
—